SGCM
MRTX

Sand Grove Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Sand Grove Capital Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-224,632
Closed -$13.2M – 30
2023
Q4 		$13.2M Buy
+224,632
New +$13.2M 3.51% 10